Conversely, treatment with si-NEAT1 lentivirus reduced the triglyceride and cholesterol levels in the animal model, further supporting the involvement of NEAT1 in NAFLD progression. The gene discussed is NEAT1; the disease is metabolic dysfunction-associated steatotic liver disease.